RIG enters its July 27 earnings window with a notable split: short sellers have been trimming positions all week, yet the stock remains one of the most heavily shorted names in its sector and is down 16% over the past month.
The short position tells most of the story. Nearly 19% of Transocean's free float is borrowed against the stock — a high absolute level, even after a 4% week-on-week decline in shares short to around 209 million. The direction of travel is mildly encouraging for bulls: shorts have been unwinding since late June, when the position was closer to 221 million shares. But the ORTEX short score, at 62.5 and sitting in just the 7th percentile of the broader universe on the short score rank, signals that relative bearish pressure remains firmly elevated. Borrow, by contrast, is almost comically cheap — the cost to borrow has edged up to around 0.57%, a one-month high but still deep in "easy" territory. Availability has swung sharply looser, now running at roughly 500% — meaning there are around five shares available to borrow for every one already borrowed — the widest it has been in at least a year. That loosening reflects the unwinding shorts returning shares to the pool rather than any structural change in the bear thesis. Taken together, shorts are covering at the margin, but borrow conditions present no friction to anyone wishing to re-establish a position.
Options positioning leans slightly more constructive than it has been. The put/call ratio has drifted down to 0.62, fractionally below its 20-day average of 0.67 and well beneath the late-June peak above 0.79. That's a mild lean toward calls, though the z-score of -0.91 places it only modestly below the mean — options traders look more neutral than outright bullish, and the move likely reflects some hedges being lifted rather than new conviction buying.
The Street is broadly non-committal, with five analysts holding a Hold consensus and a mean price target of $6.35 — implying roughly 26% upside from the current $5.02. Susquehanna lowered its target this morning from $8 to $7 while keeping a Positive rating — the clearest signal yet that even the relative bulls are acknowledging the damage the stock has done. Barclays upgraded to Overweight back in May with an $8 target, and Morgan Stanley runs an Equal-Weight at $7, so the range is clustered in the $6–$8 zone. The price-to-book multiple has compressed meaningfully, down nearly 0.2x over 30 days to 0.69x, which reflects both the stock's 16% monthly decline and some incremental earnings-estimate pressure. EV/EBITDA at 8.3x has been relatively stable. The factor score picture is weak across the board: RIG ranks in the bottom decile on short score, 21st percentile on days-to-cover, and 28th on dividend. The sector score sits at the midpoint.
Chairman Chad Deaton's open-market purchase of 35,000 shares at $4.95 on July 2 is worth flagging — it is modest in dollar terms ($173,000) but came immediately after a period of insider selling in late May, when Deaton, a director, and the chief legal officer all sold shares around $6.70–$7.45. The net 90-day insider position is just barely positive at about 503,000 shares, largely reflecting award grants in May rather than conviction buying. The Deaton purchase is a small data point, but it is the first open-market buy from the chair in the window, and it came close to what appears to be a short-term price low.
The earnings track record adds a cautionary note to the setup. Both of Transocean's available recent results triggered sharp one-day falls — the May 2026 print sent the stock down around 9% on the day and a further 5% over the following week. Peer VAL is flat on the week while NE added about 0.6%, suggesting RIG's modest 2.7% weekly gain partly reflects catch-up rather than a sector-wide re-rating. The July 27 print — and with it any update on contract backlog, deepwater day-rate trends, and the debt load that defines the bull-bear debate — is the next moment that matters.
See the live data behind this article on ORTEX.
Open RIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
